Johan M. Spoor's Net Worth
$1.77 Million
Who is Johan M. Spoor?
Johan M. Spoor has an estimated net worth of $1.77 Million. This is based on reported shares across multiple companies, which include FLUOROPHARMA MEDICAL, INC., MetaStat, Inc., AtheroNova Inc., AzurRx BioPharma, Inc., Perspective Therapeutics, Inc., and Protea Biosciences Group, Inc..
SEC CIK
Johan M. Spoor's CIK is 0001535289
Past Insider Trading and Trends
2014 was Johan M. Spoor's most active year for acquiring shares with 8 total transactions. Johan M. Spoor's most active month to acquire stocks was the month of November. 2017 was Johan M. Spoor's most active year for disposing of shares, totalling 1 transactions. Johan M. Spoor's most active month to dispose stocks was the month of October. 2024 saw Johan M. Spoor paying a total of $117,430.00 for 600,000 shares, this is the most they've acquired in one year. In 2017 Johan M. Spoor cashed out on 100,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FLUOROPHARMA MEDICAL, INC. No price found
CEO, PRESIDENT, CHAIRMAN
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.25% | 10K |
$0.50 | $5,000.00 | 200.4K |
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 4
| +5.54% | 10K |
$0.76 | $7,550.00 | 190.4K |
Nov 26
| |||
Form 4
| +38.34% | 50K |
—
|
—
| 180.4K |
Sep 27
| |||
Form 4
| +62.19% | 50K |
$0.80 | $40,000.00 | 130.4K |
Sep 12
| |||
Form 4
| +6.63% | 5K |
$0.84 | $4,200.00 | 80.4K |
Aug 3
| |||
Form 4
| +8.65% | 6K |
$0.82 | $4,920.00 | 75.4K |
Jun 15
| |||
Form 4
| +7.20% | 5K |
$1.00 | $5,000.00 | 74.4K |
Nov 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MetaStat, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 31 - May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31 - May 18
| |||
Form 4
| +39.65% | 104.94K |
—
|
—
| 369.6K |
Oct 14
| |||
Form 4
| +23.29% | 50K |
—
|
—
| 264.67K |
Jul 22
| |||
Form 4
| +231.95% | 150K |
—
|
—
| 214.67K |
Apr 9
| |||
Form 4
| +340.88% | 50K |
—
|
—
| 64.67K |
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AtheroNova Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AzurRx BioPharma, Inc. (FWBI) No price found
PRESIDENT AND CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 4
| +12.86% | 38.58K |
$1.30 | $49,968.84 | 338.62K |
Dec 28
| |||
Form 4
| +199.93% | 200K |
—
|
—
| 300.03K |
Jul 12
| |||
Form 4
| +294,117.65% | 100K |
$1.00 | $100,000.00 | 100.03K |
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Perspective Therapeutics, Inc. (CATX) Snapshot price: $15.26
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +266.16% | 100K |
$1.17 | $117,430.00 | 137.57K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||